FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.

Lupin Pharmaceuticals announced on December 1, 2016, the FDA approval of hydrocodone bitartrate and acetaminophen tablets, an ANDA filing, expanding the generics landscape for a widely used opioid combination. This approval allows Lupin to introduce a cost-effective entry into the market, mimicking branded formulations and intensifying competitive pricing amidst ongoing skepticism regarding opioid utilization.